These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

185 related items for PubMed ID: 36718644

  • 1. The miR-27a-3p/FTO axis modifies hypoxia-induced malignant behaviors of glioma cells.
    Du P, Meng L, Liao X, Liu Y, Mo X, Gong M, Liao Y.
    Acta Biochim Biophys Sin (Shanghai); 2023 Jan 25; 55(1):103-116. PubMed ID: 36718644
    [Abstract] [Full Text] [Related]

  • 2. M6A RNA Methylation-Based Epitranscriptomic Modifications in Plasticity-Related Genes via miR-124-C/EBPα-FTO-Transcriptional Axis in the Hippocampus of Learned Helplessness Rats.
    Roy B, Ochi S, Dwivedi Y.
    Int J Neuropsychopharmacol; 2022 Dec 12; 25(12):1037-1049. PubMed ID: 36161325
    [Abstract] [Full Text] [Related]

  • 3. The FTO/miR-181b-3p/ARL5B signaling pathway regulates cell migration and invasion in breast cancer.
    Xu Y, Ye S, Zhang N, Zheng S, Liu H, Zhou K, Wang L, Cao Y, Sun P, Wang T.
    Cancer Commun (Lond); 2020 Oct 12; 40(10):484-500. PubMed ID: 32805088
    [Abstract] [Full Text] [Related]

  • 4. RNA N6-methyladenosine demethylase FTO promotes breast tumor progression through inhibiting BNIP3.
    Niu Y, Lin Z, Wan A, Chen H, Liang H, Sun L, Wang Y, Li X, Xiong XF, Wei B, Wu X, Wan G.
    Mol Cancer; 2019 Mar 28; 18(1):46. PubMed ID: 30922314
    [Abstract] [Full Text] [Related]

  • 5. Extracellular vesicles carry miR-27a-3p to promote drug resistance of glioblastoma to temozolomide by targeting BTG2.
    Chen L, Li Z, Hu S, Deng Q, Hao P, Guo S.
    Cancer Chemother Pharmacol; 2022 Feb 28; 89(2):217-229. PubMed ID: 35039898
    [Abstract] [Full Text] [Related]

  • 6. MicroRNA-210-3p is transcriptionally upregulated by hypoxia induction and thus promoting EMT and chemoresistance in glioma cells.
    Liu H, Chen C, Zeng J, Zhao Z, Hu Q.
    PLoS One; 2021 Feb 28; 16(7):e0253522. PubMed ID: 34197482
    [Abstract] [Full Text] [Related]

  • 7. microRNA-96 promotes occurrence and progression of colorectal cancer via regulation of the AMPKα2-FTO-m6A/MYC axis.
    Yue C, Chen J, Li Z, Li L, Chen J, Guo Y.
    J Exp Clin Cancer Res; 2020 Nov 12; 39(1):240. PubMed ID: 33183350
    [Abstract] [Full Text] [Related]

  • 8. FTO Inhibition Enhances the Antitumor Effect of Temozolomide by Targeting MYC-miR-155/23a Cluster-MXI1 Feedback Circuit in Glioma.
    Xiao L, Li X, Mu Z, Zhou J, Zhou P, Xie C, Jiang S.
    Cancer Res; 2020 Sep 15; 80(18):3945-3958. PubMed ID: 32680921
    [Abstract] [Full Text] [Related]

  • 9. LncRNA HCP5 promotes cell proliferation and inhibits apoptosis via miR-27a-3p/IGF-1 axis in human granulosa-like tumor cell line KGN.
    Chen Y, Zhang X, An Y, Liu B, Lu M.
    Mol Cell Endocrinol; 2020 Mar 01; 503():110697. PubMed ID: 31891769
    [Abstract] [Full Text] [Related]

  • 10. FTO-mediated epigenetic upregulation of LINC01559 confers cell resistance to docetaxel in breast carcinoma by suppressing miR-1343-3p.
    Lin W, Mo CQ, Kong LJ, Chen L, Wu KL, Wu X.
    Kaohsiung J Med Sci; 2023 Sep 01; 39(9):873-882. PubMed ID: 37584416
    [Abstract] [Full Text] [Related]

  • 11. Ligustrazine promotes hypoxia/reoxygenation-treated trophoblast cell proliferation and migration by regulating the microRNA-27a-3p/ATF3 axis.
    Wang M, Zhang L, Huang X, Sun Q.
    Arch Biochem Biophys; 2023 Mar 15; 737():109522. PubMed ID: 36657605
    [Abstract] [Full Text] [Related]

  • 12. Glioblastoma upregulates SUMOylation of hnRNP A2/B1 to eliminate the tumor suppressor miR-204-3p, accelerating angiogenesis under hypoxia.
    Guo Q, Fan Y, Wang Q, Li B, Qiu W, Qi Y, Pan Z, Zhang S, Zhao S, Yang K, Xu H, Li M, Gao Z, Xu J, Wang H, Wang S, Tang Q, Qiu J, Guo X, Deng L, Zhang P, Zhao R, Xue H, Wang C, Li G.
    Cell Death Dis; 2023 Feb 21; 14(2):147. PubMed ID: 36810326
    [Abstract] [Full Text] [Related]

  • 13. Hypoxic signature of microRNAs in glioblastoma: insights from small RNA deep sequencing.
    Agrawal R, Pandey P, Jha P, Dwivedi V, Sarkar C, Kulshreshtha R.
    BMC Genomics; 2014 Aug 17; 15(1):686. PubMed ID: 25129238
    [Abstract] [Full Text] [Related]

  • 14. Sevoflurane inhibits the apoptosis of hypoxia/reoxygenation-induced cardiomyocytes via regulating miR-27a-3p-mediated autophagy.
    Zhang Y, Zhan B, Hu Y, Chen S, Zhang Q.
    J Pharm Pharmacol; 2021 Oct 07; 73(11):1470-1479. PubMed ID: 34383044
    [Abstract] [Full Text] [Related]

  • 15. LncRNA DNAJC3-AS1 promotes the biological functions of papillary thyroid carcinoma via regulating the microRNA-27a-3p/CCBE1 axis.
    Ni T, Li Y, Guo D, Tan L, Xiao Z, Shi Y.
    Cell Biol Int; 2023 Mar 07; 47(3):539-547. PubMed ID: 36583660
    [Abstract] [Full Text] [Related]

  • 16. Long Noncoding RNA SOX2-OT Exacerbates Hypoxia-Induced Cardiomyocytes Injury by Regulating miR-27a-3p/TGFβR1 Axis.
    Yang G, Lin C.
    Cardiovasc Ther; 2020 Mar 07; 2020():2016259. PubMed ID: 32528555
    [Abstract] [Full Text] [Related]

  • 17. CircBCAR3 accelerates esophageal cancer tumorigenesis and metastasis via sponging miR-27a-3p.
    Xi Y, Shen Y, Wu D, Zhang J, Lin C, Wang L, Yu C, Yu B, Shen W.
    Mol Cancer; 2022 Jul 15; 21(1):145. PubMed ID: 35840974
    [Abstract] [Full Text] [Related]

  • 18. D-2-HG Inhibits IDH1mut Glioma Growth via FTO Inhibition and Resultant m6A Hypermethylation.
    Pianka ST, Li T, Prins TJ, Eldred BSC, Kevan BM, Liang H, Zapanta Rinonos S, Kornblum HI, Nathanson DA, Pellegrini M, Liau LM, Nghiemphu PL, Cloughesy TF, Lai A.
    Cancer Res Commun; 2024 Mar 22; 4(3):876-894. PubMed ID: 38445960
    [Abstract] [Full Text] [Related]

  • 19. Circ_0010729 regulates hypoxia-induced cardiomyocyte injuries by activating TRAF5 via sponging miR-27a-3p.
    Lei D, Wang Y, Zhang L, Wang Z.
    Life Sci; 2020 Dec 01; 262():118511. PubMed ID: 33010282
    [Abstract] [Full Text] [Related]

  • 20. Overexpression of FTO alleviates osteoarthritis by regulating the processing of miR-515-5p and the TLR4/MyD88/NF-κB axis.
    Cai D, Zhang J, Yang J, Lv Q, Zhong C.
    Int Immunopharmacol; 2023 Jan 01; 114():109524. PubMed ID: 36538851
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.